“This is a bit of a moonshot for J&J.” Chairman and CEO of Johnson & Johnson Alex Gorsky discusses its experimental vaccine for COVID-19 that will begin clinical trials by September, and could be available for emergency use authorization in early 2021. Former FDA Commissioner Dr. Scott Gottlieb says deaths in the U-S related to the virus would likely peak toward the end of April and suggests that life might start returning to normal after the middle of May.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.